Compass Pathways PLC

5Y6

Company Profile

  • Business description

    Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

  • Contact

    33 Broadwick Street
    LondonW1F 0DQ
    GBR

    E: [email protected]

    https://compasspathways.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Care Facilities

    Fiscal Year End

    31 December 2026

    Employees

    166

Stocks News & Analysis

stocks

Does SpaceX’s sky-high valuation make sense?

SpaceX’s $1.5 trillion valuation looks expensive and risky, but not irrational.
stocks

ASX healthcare leader sees further cuts to fair value

Fiercer competition expected to squeeze margins.
stocks

Avoid this overpriced ASX share

This ASX share is 84% overvalued and lacks a sustainable competitive advantage.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,976.8020.700.23%
CAC 408,000.5956.77-0.70%
DAX 4023,659.25309.38-1.29%
Dow JONES (US)47,706.5134.29-0.07%
FTSE 10010,324.7387.51-0.84%
HKSE25,898.7661.14-0.24%
NASDAQ22,697.101.160.01%
Nikkei 22555,025.37776.981.43%
NZX 50 Index13,293.13198.761.52%
S&P 5006,781.4814.51-0.21%
S&P/ASX 2008,743.5019.400.22%
SSE Composite Index4,133.4310.290.25%

Market Movers